[ad_1]
The Canadian medical marijuana company Tilray began trading on the NYSE on the Nasdaq index on Thursday, with a 31.71% market share.
Tilray, dedicated to the research, cultivation, processing and distribution of medicinal marijuana on a global scale, was the first of its kind to make an initial public offering on a US stock exchange. .
The stock market debut was made under the label "TLRY", with an offer of nine million shares and a reference price of 17 dollars (14.6 euros). After the 31.71% increase recorded on the day of its debut, the value of the bond Tilray closed the session at $ 22.39
The company has cashed $ 153 million from its IPO and its market value According to analysts, they have located most of the new investors in the United States
This specialized company joins two other Canadian marijuana companies already present in the US market, Cronos, which made its Nasdaq debut in February, and Canopy, which started in May
These two companies were already listed on Canadian stock exchanges, unlike Tilray, which chose the United States to make its initial public offering, coincides with as Canada prepares to legalize the plant for recreational purposes next October.
Tilray is controlled by the US investment firm Privateer, which intends to retain a portion of the revenues now earned and allocate another portion to finance new cultivation and processing facilities in Ontario [19659008] Facebook “/>
Share this post
